Literature DB >> 2191728

Skin conductance habituation in panic disorder patients.

W T Roth1, A Ehlers, C B Taylor, J Margraf, W S Agras.   

Abstract

Skin conductance habituation was compared between 38 patients meeting DSM-III criteria for Panic Disorder and 29 normal controls. Approximately half of each group was randomly assigned to be given 100 dB SPL tones and the other half 75 dB tones. All indices pointed to slowed habituation in patients compared with normals: number of trials to response habituation, total number of responses, and slope of decline of skin conductance level. Patient-normal differences were not significantly larger for 100 dB than for 75 dB. In addition, patients compared with normals had more nonspecific fluctuations, higher skin conductance levels, and a shorter response latency to the first stimulus. Stepwise discriminant analyses classified patients and normals better in the 100 dB than in the 75 dB condition, and showed that the various skin conductancy variables were largely redundant at the higher intensity.

Entities:  

Mesh:

Year:  1990        PMID: 2191728     DOI: 10.1016/0006-3223(90)90421-w

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  14 in total

1.  Twenty-four hour skin conductance in panic disorder.

Authors:  Sigrun Doberenz; Walton T Roth; Eileen Wollburg; Christoph Breuninger; Sunyoung Kim
Journal:  J Psychiatr Res       Date:  2010-05-27       Impact factor: 4.791

2.  Ventromedial prefrontal cortex activity and rapid eye movement sleep are associated with subsequent fear expression in human subjects.

Authors:  V I Spoormaker; G A Gvozdanovic; P G Sämann; M Czisch
Journal:  Exp Brain Res       Date:  2014-01-23       Impact factor: 1.972

3.  Auditory event-related potentials in panic disorder.

Authors:  A Iwanami; H Isono; Y Okajima; K Kamijima
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

4.  Does anxiety sensitivity correlate with startle habituation? An examination in two independent samples.

Authors:  Miranda L Campbell; Stephanie M Gorka; Sarah K McGowan; Brady D Nelson; Casey Sarapas; Andrea C Katz; E Jenna Robison-Andrew; Stewart A Shankman
Journal:  Cogn Emot       Date:  2013-06-07

5.  Physiological, biochemical and subjective parameters in anxiety patients with panic disorder during stress exposure as compared with healthy controls.

Authors:  T Hoehn; S Braune; G Scheibe; M Albus
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

6.  Time course of threat responding in panic disorder and depression.

Authors:  Stephanie M Gorka; Huiting Liu; Casey Sarapas; Stewart A Shankman
Journal:  Int J Psychophysiol       Date:  2015-07-11       Impact factor: 2.997

Review 7.  The genetics of anxiety-related negative valence system traits.

Authors:  Jeanne E Savage; Chelsea Sawyers; Roxann Roberson-Nay; John M Hettema
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-05-19       Impact factor: 3.568

8.  Association between respiratory sinus arrhythmia and reductions in startle responding in three independent samples.

Authors:  Stephanie M Gorka; Sarah Kate McGowan; Miranda L Campbell; Brady D Nelson; Casey Sarapas; Jeffrey R Bishop; Stewart A Shankman
Journal:  Biol Psychol       Date:  2013-03-23       Impact factor: 3.251

9.  Reversible inactivation of rostral nucleus raphe pallidus attenuates acute autonomic responses but not their habituation to repeated audiogenic stress in rats.

Authors:  Tara J Nyhuis; Cher V Masini; Kirsten L Taufer; Heidi E W Day; Serge Campeau
Journal:  Stress       Date:  2016-03-21       Impact factor: 3.493

10.  Evidence for the Integration of Stress-Related Signals by the Rostral Posterior Hypothalamic Nucleus in the Regulation of Acute and Repeated Stress-Evoked Hypothalamo-Pituitary-Adrenal Response in Rat.

Authors:  Tara J Nyhuis; Cher V Masini; Heidi E W Day; Serge Campeau
Journal:  J Neurosci       Date:  2016-01-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.